Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest

dc.contributor.authorVelegraki, A.en
dc.contributor.authorAlexopoulos, E. C.en
dc.contributor.authorKritikou, S.en
dc.contributor.authorGaitanis, G.en
dc.date.accessioned2015-11-24T18:55:33Z
dc.date.available2015-11-24T18:55:33Z
dc.identifier.issn0095-1137-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18898
dc.rightsDefault Licence-
dc.subjectAntifungal Agents/*pharmacologyen
dc.subjectCulture Mediaen
dc.subjectFatty Acidsen
dc.subjectHumansen
dc.subjectMalassezia/*drug effectsen
dc.subjectMicrobial Sensitivity Testsen
dc.subjectMycoses/epidemiology/microbiologyen
dc.subjectTriazoles/*pharmacologyen
dc.titleUse of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etesten
heal.abstractA novel formulation of RPMI 1640 medium for susceptibility testing of Malassezia yeasts by broth microdilution (BMD) and Etest is proposed. A modification of the NCCLS M27-A2 BMD method was used to test 53 isolates of Malassezia furfur (12 isolates), M. sympodialis (8 isolates), M. slooffiae (4 isolates), M. globosa (22 isolates), M. obtusa (2 isolates), M. restricta (2 isolates), M. pachydermatis (1 isolates), and M. dermatis (2 isolates) against amphotericin B, ketoconazole, itraconazole, fluconazole, voriconazole, terbinafine, and posaconazole by BMD and Etest. RPMI and antibiotic medium 3 (AM3) were supplemented with glucose, bile salts, a mixture of fatty acids, and n-octadecanoate fatty acids and Tween 20. M. furfur ATCC 14521 and M. globosa ATCC 96807 were used as quality control strains. Depending on the species, MICs were read after 48 or 72 h of incubation at 32 degrees C. Low azole and terbinafine MICs were recorded for all Malassezia species, whereas amphotericin B displayed higher MICs (>/=16 microg/ml) against M. furfur, M. restricta, M. globosa, and M. slooffiae strains, which were AM3 confirmed. Agreement of the two methods was 84 to 97%, and intraclass correlation coefficients were statistically significant (P < 0.001). Because of higher amphotericin B MICs provided by Etest for strains also displaying high BMD MICs (>/=1 microg/ml), agreement was poorer. The proposed media are used for the first time and can support optimum growth of eight Malassezia species for recording concordant BMD and Etest MICs.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1128/JCM.42.8.3589-3593.2004-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15297502-
heal.identifier.secondaryhttp://jcm.asm.org/content/42/8/3589.full.pdf-
heal.journalNameJ Clin Microbiolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2004-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Πρωτότυπος φάκελος/πακέτο

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
Velegraki-2004-Use of fatty acid RP.pdf
Μέγεθος:
522.86 KB
Μορφότυπο:
Adobe Portable Document Format

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: